NFX BIO
NFX Bio is a fund initiative that seeks to invest in scientist-founders at the seed stage with a technology platform approach. Led by Omri Amirav Drory, a venture partner with NFX, who founded Genome Compiler, it helps scientists learn to be founders and guides biology companies with information technology to be a critical distinction with massive implications.
NFX BIO
Industry:
Biotechnology Financial Services Impact Investing Information Technology
Founded:
2021-01-01
Status:
Active
Similar Organizations
Tahoma Ventures
Tahoma Ventures provides early stage capital to IT technology startups.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-02 | Eleven Therapeutics | NFX Bio investment in Seed Round - Eleven Therapeutics | 22 M USD |
| 2021-06-06 | Pangea Therapeutics Ltd. | NFX Bio investment in Seed Round - Pangea Therapeutics Ltd. | N/A |